Difference between revisions of "Team:Nagahama/Proof of concept"
| Line 378: | Line 378: | ||
<li class="menu_item"> <div class="icon plus"></div> PROJECT | <li class="menu_item"> <div class="icon plus"></div> PROJECT | ||
<ul class="submenu"> | <ul class="submenu"> | ||
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Introduction"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Introduction"> ・Introduction </a></li> |
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Result and Discussion"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Result and Discussion"> ・Result and Discussion </a></li> |
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Future"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Future"> ・Future </a></li> |
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Protocol"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Protocol"> ・Protocol </a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
| Line 387: | Line 387: | ||
<li class="menu_item"> <div class="icon plus"></div> BioBricks | <li class="menu_item"> <div class="icon plus"></div> BioBricks | ||
<ul class="submenu"> | <ul class="submenu"> | ||
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Our all BioBricks"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Our all BioBricks"> ・Our all BioBricks </a></li> |
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/BioBricks for medal"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/BioBricks for medal"> ・BioBricks for medal </a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
| Line 397: | Line 397: | ||
<li class="menu_item"> <div class="icon plus"></div> Attributions | <li class="menu_item"> <div class="icon plus"></div> Attributions | ||
<ul class="submenu"> | <ul class="submenu"> | ||
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Team"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Team"> ・Team</a></li> |
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Attributions"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Attributions"> ・Attributions </a></li> |
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Sponsors"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Sponsors"> ・Sponsors</a></li> |
</ul> | </ul> | ||
| Line 407: | Line 407: | ||
<li class="menu_item"> <div class="icon plus"></div> Collaborations | <li class="menu_item"> <div class="icon plus"></div> Collaborations | ||
<ul class="submenu"> | <ul class="submenu"> | ||
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Collaborations"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Collaborations"> ・Collaborations</a></li> |
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/The Annual Meeting Of The Genetics Society Of Japan"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/The Annual Meeting Of The Genetics Society Of Japan"> ・The Annual Meeting Of The Genetics Society Of Japan </a></li> |
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Support Gifu"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Support Gifu"> ・Support Gifu</a></li> |
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/virginia"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/virginia"> ・Virginia</a></li> |
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Paris-Saclay"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Paris-Saclay"> ・Paris-Saclay</a></li> |
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Munich United"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Munich United"> ・Munich United</a></li> |
| Line 422: | Line 422: | ||
<li class="menu_item"> <div class="icon plus"></div> Human Practice | <li class="menu_item"> <div class="icon plus"></div> Human Practice | ||
<ul class="submenu"> | <ul class="submenu"> | ||
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Human Practice"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Human Practice"> ・Human Practice </a></li> |
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Contacting Local"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Contacting Local"> ・Contacting Local</a></li> |
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Contacting Japan"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Contacting Japan"> ・Contacting Japan</a></li> |
| − | <li> <a href="https://2016.igem.org/Team:Nagahama/Intgrated Human Practice"> | + | <li> <a href="https://2016.igem.org/Team:Nagahama/Intgrated Human Practice"> ・Intgrated Human Practice</a></li> |
Latest revision as of 16:12, 19 October 2016
ＭarA
This device makes Escherichia coli have the resistance of farnesol. Actually, we confirmed resistance of farnesol by MarA.
Colony formation of E. coli JM109 engineered with marA on farnesol overlaid plates.
Fig.7:Colony formation of E. coli JM109 engineered with marA on farnesol overlaid plates.
E.coli JM109 and E.coli JM109 (marA) were dropped on LBGMg agar plates in serial ten-fold dilutions (10⁻¹～〖10〗^(-6)), overlaid with 30 % (v/v) farnesol hexane solution (farnesol solution) and incubated at 30°C for 24 h. This figure shows that E.coli JM109 (marA) cells that overexpress the marA product better than the control E.coli JM109 wild type cells survived plates overloyed by 30 % farnesol solution.
E.coli JM109 and E.coli JM109 (marA) were dropped on LBGMg agar plates in serial ten-fold dilutions (10⁻¹～〖10〗^(-6)), overlaid with 30 % (v/v) farnesol hexane solution (farnesol solution) and incubated at 30°C for 24 h. This figure shows that E.coli JM109 (marA) cells that overexpress the marA product better than the control E.coli JM109 wild type cells survived plates overloyed by 30 % farnesol solution.
From the results, the device we built performs its desired function.
